Overview

18F-DCFPyL PET-CT Scan and Prostate Cancer

Status:
Unknown status

Trial end date:
2020-06-30

Target enrollment:

Participant gender:

Summary

Primary Objective: The primary objective of this study is to assess the efficacy of 18F-DCFPyL PET-CT for initial staging of prostate cancer in Veterans compared to conventional imaging (99mTc-MDP bone scan and Diagnostic CT or MRI). The primary clinical endpoint of our study is the percent of Veterans with prostate cancer in which the 18F-DCFPyL PET-CT identifies M1 disease at initial staging. Secondary Objectives: Frequency of the change in primary treatment plan after initial staging.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Lida Jafari

Collaborator:

University of California, Los Angeles